KRAS G12C inhibitor 19
KRAS G12C inhibitor 19 is a potent and selective small molecule targeting the KRAS G12C mutation. It demonstrates robust anti-proliferative activity in vitro and has shown efficacy in inhibiting tumor growth in vivo, making it a valuable tool for oncology research focused on RAS-driven cancers.
Product Specifications
CAS Number
2649788-46-3
Product Name Alternative
KRAS G12C, KRAS G12C inhibitor 19, KRAS G-12C inhibitor 19
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
97.46% (May vary between batches)
Solubility
DMSO:52.9 mg/mL (100.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:10 mg/mL (18.91 mM)
Smiles
C (#N) C=1C2=C (C=CC (F) =C2SC1N) C=3C (Cl) =C4C (=CC3F) C (=O) N5[C@@] (CCO4) (CN (C (C=C) =O) CC5) [H]
Molecular Formula
C25H19ClF2N4O3S
Molecular Weight
528.96
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15324235 1 Vial
Lentiviral human CCDC91 shRNA (UAS) - Lentiviral human CCDC91 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 